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Abstract 
 
 PHO13 in Saccharomyces cerevisiae (budding yeast) is a para-nitrophenyl 
phosphatase (pNppase) of the haloacid dehalogenase (HAD) superfamily. A biological 
substrate for PHO13 had remained undiscovered while a knockout phenotype has only 
been observed in strains engineered to grow on D-xylose. The purified enzyme has been 
identified in our lab to specifically hydrolyze 2-phosphoglycolate, classifying it as a 
phosphoglycolate phosphatase (PGPase). In photosynthetic organisms, 2-
phosphoglycolate (2-PG) is generated by the oxygenation reaction of ribulose-1,5-
bisphosphate carboxylase (RuBisCO) in the Calvin Cycle. To be recycled back into 
general metabolism, photosynthetic PGPase converts 2-PG to glycolate. In non-
photosynthetic yeast, 2-PG must be generated by some other mechanism, possibly by 
DNA oxidative damage, but would nonetheless need to be catabolized due to its ability to 
inhibit triose phosphate isomerase (TPI). Yeast cells lacking functional Pho13p (pho13Δ) 
were investigated for phenotypes that support TPI1 inhibition including the ability to 
adapt in the presence of hyperosmotic media (1M NaCl) and the inability to grow in the 
absence of inositol. Cells lacking Pho13p did not exhibit an obvious phenotype under 
either condition. To increase intracellular levels of 2-PG, cells were additionally treated 
with hydrogen peroxide. The pho13Δ strain appeared to exhibit a hypersensitive growth 
phenotype in the presence of hydrogen peroxide when grown under limiting nutrient 
conditions. However, when complementation was attempted with this phenotype, 
variability was observed among pho13Δ strains using different expression vectors. 
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INTRODUCTION 
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It is important to characterize the function of newly discovered genes within the 
genome to further advances in medicine, chemistry, and other areas of research.1 A broad 
understanding of the metabolic and physiological capabilities of an organism’s genome 
will aid identifying new chemotherapeutic and antibiotic targets.1 With greater 
knowledge of enzyme function, new discoveries for protein design and redesign can 
improve enzyme activity for novel reactions.2 In the age of genomic sequencing, protein 
function determination lags behind protein sequence idetification.1  
Proteins are annotated by their similarities to other proteins based on sequence 
homology but often do not have a functional relationship.2 Approximately 30-50% of 
proteins in a newly-sequenced genome are functionally unannotated or misannotated.2 To 
help determine reliable functions for uncharacterized enzymes, the Enzyme Function 
Initiative (EFI) was established. EFI is a consortium of researchers from six institutions 
across the U.S. whose goal is to functionally annotate enzymes that have either been 
mislabeled or uncharacterized.1 The EFI is accomplishing this by integrating 
computational and biological methods.2 The biochemical experimentational approach is 
not a feasible high-throughput method and computational approaches have potential to 
help annotate proteins on a larger scale.1 These new methods could provide the medical 
community a greater understanding of some enzymes that could have physiological 
importance.1 By doing this work, it is hoped to reduce the gap between sequenced data 
and protein function.3   
For genes that have been successfully cloned and purified, the “funnel” for 
functional assignment transitions from computational approaches to more emphasis on 
experimental approaches.1 While functional characterization of a purified protein in vitro 
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is key in this process, confirmation of enzymatic activity is typically sought through “in 
vivo” techniques. Among the various techniques used including overexpression studies, 
transcriptomics and metabolomics, gene knockout is commonly employed.1 Additionally, 
for a gene knockout study to be useful, deletion of the gene should result in an observable 
phenotype that makes sense physiologically.4 This is traditionally the strongest evidence 
to support a newly characterized protein function. 
HAD Superfamily 
 The Haloacid Dehalogenase (HAD) superfamily exists in all three domains of life 
and is comprised of enzymes that catalyze the hydrolysis of a phosphate group from a 
substrate.5,6,7 While the HAD name derives from a 2-haloacid dehalogenase,5 five 
different classifications of enzymes of this superfamily currently exist; haloacid 
dehalogenases, phosphatases, ATPases, phosphonatases, and phosphohexomutases.5 
Haloacid dehalogenases, catalyzes the replacement of an halide R group (leaving group) 
for an alcohol after nucleophile attack.5 Phosphatases and ATPases cleave a phosphate 
group from a phosphate monoester and phosphoanhydride bond, respectively.5 
Phosphonatases cleave a phosphate group from a phosphonacetylaldehyde to liberate 
inorganic phosphate. Phosphohexomutases catalyze group transfer of a phosphate group 
from one carbon atom on a phosphosugar substrate to a different carbon atom.5 Members 
that catalyze this function contain a phosphate moiety attached to the nucleophilic 
residue.5
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Figure 1. The first member discovered, haloacid dehalogenases reaction. A 
nucleophile attack results in an halide leaving group.5 Prepared using ChemSketch. 
 
Of these five activities, approximately 79% of the HAD superfamily members function as 
phosphatases, 20% function as ATPases, and the remaining 1% catalyze the other 
substrates.6,7 The general reaction mechanism of each member involves the use of an 
aspartate nucleophile (fig 1). 
Rossmann Fold of the Core Domain 
Members of the HAD superfamily share a similar structure, the HAD Rossmann 
fold (fig 2).8 A Rossmann fold is a general protein motif that allows nucleotides to bind.9 
The HAD Rossmann fold is an ‘α,β-core domain with a central parallel β sheet that is 
flanked by α-helices’.8 Within the core domain there are four catalytic core motifs with 
cap insertion sites that allow substrate specificity within the HAD superfamily.8 The 
HAD Rossmann fold, additionally, has two unique structural motifs, the “squiggle” and 
“flap”.5,7,8 The squiggle is located downstream of the first catalytic core motif (fig 2, 
pink), and forms a nearly complete helical turn.7 The flap is also located immediately 
after the squiggle (fig 2, green) adopting a β-hairpin structure.7 The squiggle can be either 
in a tight or loose confirmation, causing a conformational change to the active site.5  
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Figure 2. HAD Rossmann fold. Contains four catalytic residues and cap insertion site. 
The core domain is the conserved motif and has an ‘α,β- core domain with a central 
parallel β sheet that is flanked by α-helices’.8 The conserved catalytic core residues are 
within motifs 1, 2, 3, & 4. The cap insertion sites for subfamily I/III or subfamily II help 
determine substrate specificity.6 Prepared using Adobe Illustrator CC. 
 
The HAD superfamily Rossmann fold has a three-layered α,β-core domain 
containing four conserved catalytic core motifs, located within the loop regions, which 
contributes to the catalytic features of the active site.6 The metal cofactor (e.g. 
magnesium, cobalt, manganese) is bound to the bottom of the active site near the catalytic 
core residues.10 
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Core Domain/Residues 
 There are over 3000 sequenced proteins within the HAD superfamily and these 
proteins are categorized into the HAD superfamily based on four conserved sequence 
motifs.5,8 
 
Figure 3. Four conserved sequence motifs of the HAD superfamily. The four 
conserved sequence motif are highlighted in yellow and labeled as I, II, III, and IV. The 
sequence alignments are of the eight enzymes that are known to be in the para-
nitrophenyl phosphatase subfamily. Each organism and its enzyme are labeled. 
 
The first conserved sequence motif (motif 1) is located prior to the beta hairpin 
(Subfamily I/III Cap Insertion) (fig 2). It contains two aspartates. The first acts as a 
nucleophile and the second (Asp+2) functions as a general acid/base catalyst (fig 3&4).5,7 
The second conserved sequence motif contains amino acid residues serine or 
	   7	  
threonine (motif 2) (fig 3&4). This motif functions by binding a hydrogen with the 
phosphoryl group of the substrate, stabilizing the intermediate of the catalytic reaction.5,7 
The third conserved sequence motif (motif 3) contains lysine or arginine (fig 2&4) that 
serves to create a salt bridge to further stabilize the negatively charged intermediate.5,7 
The fourth conserved sequence motif (motif 4) (fig 2) is responsible for the coordination 
of the magnesium ion cofactor (fig 4).5,7 Motifs I and IV are needed to stabilize the active 
site via binding with a divalent metal ion, magnesium.5,8 The active site is neutralized by 
the coordination of an divalent metal cofactor with the nucleophilic aspartate and the 
substrate phosphate.5,7 The magnesium ion also provides stability to the HAD Rossmann 
fold (fig 4).5,7 
 
Figure 4. Four catalytic motifs of the HAD Rossmann fold. Motif 1 (blue), Motif 2 
(red), Motif 3 (green) Motif 4 (purple). Prepared using ChemSketch. 
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Reaction Mechanism 
In the active site of the core domain, two partial reactions occur (fig 5). There is a 
phosphoryl group transfer from the substrate to the aspartate nucleophile and then a 
phosphoryl group transfer from the aspartylphosphate intermediate to a water molecule.6,8 
The squiggle and flap undergo conformational change preventing water in during the first 
partial reaction and then opening to allow water in during the second partial reaction.7 
The use of the catalytic aspartate residue provides a good nucleophile and leaving group, 
which has the ability to function at a low and high pH.6 
Figure 5. HAD Reaction Mechanism. The first part of the reaction, a proton is added to 
the leaving group.6 Then in the second part of the reaction the nucleophilic water 
molecule is deprotonated.6 The aspartate nucleophile acts as a good nucleophile and 
leaving group and is able to function at a low and high pH, as the Asp2 acts as a general 
acid/base.6 These reactions allow a conformational change to occur allowing the specific 
substrate to bind.6 Prepared using ChemSketch. 
 
Cap Domain 
 The cap domain, bound to the core domain, moves in a ridge-like motion, opening 
and closing the catalytic site.8 The cap domain imparts substrate specificity for the HAD 
superfamily.8 The HAD superfamily is further categorized into three families (I, II, & III) 
depending on the location and size of the cap domain.8 There are two different insertion 
sites in which the cap domain can bind.8 Subfamily I and subfamily III cap domain binds 
to the β-hairpin (fig 2, green) between loops 1 and 2.8 The cap domains of the subfamilies 
differ in size and as a result influences functional diversity.  
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The cap domain of subfamily II is inserted between loops 2 and 3 immediately 
after the beta sandwich domain (fig 2, orange).8 Subfamily II further divides into two 
diverse groups, ‘a’ and ‘b’. The secondary structure elements bound to three stranded 
anti-parallel β-sheets makes subfamily II(b) unique.5 Subfamily II(a) has four-stranded 
parallel β-sheets with a N-terminal antiparallel strand attached.5 It is known that the 
members of subfamily II(a) have activity towards para-nitrophenyl phosphate (pNpp), a 
non-natural substrate used in phosphatase assays to measure enzymatic activity.10,11,12 
Activity of II(a) members towards this substrate is also dependent on the Mg2+ cofactor 
within the active site.13  
PHO13 
The PHO13 gene encodes a pNpp phosphatase (pNppase) in Saccharomyces 
cerevisiae.10,13 Despite this activity, the physiological role of this enzyme remained to be 
determined until recently. Tuleva et al. (1998) proposed that the Pho13 protein (Pho13p) 
displays protein phosphatase activity.13 However, the large cap domain of subfamily II, 
of which Pho13p is a member, would likely prevent macromolecules from accessing the 
active site. Furthermore, a partially purified protein mixture was used in that study 
instead of the highly purified protein. Hurlimann et al. (2011) found a pho13 mutant 
strain of S. cerevisiae, identified through genetic screening, effectively dephosphorylates 
a metabolic intermediate of purine biosynthesis.14 However, the wild type Pho13p could 
not effectively dephosphorylate the same metabolite in vitro, suggesting the mutation was 
a gain-of-function attribute rather than related to the native function of Pho13p.14 
In relation to a physiological role for PHO13 in S. cerevisiae, the strongest 
evidence to date points to a role in xylose metabolism.15,16,17,18,19 One of the first 
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investigations to detect novel mutations in S. cerevisiae that could improve growth on D-
xylose used transposon mutagenesis and identified beneficial pho13 mutations.16 Using 
yeast to ferment xylose to ethanol is an important step in the development of biofuel 
sustainability as xylose comprises approximately 40% of cellulosic biomass.20 However, 
native S. cerevisiae cannot ferment xylose effectively and this results in the need to 
genetically engineer these strains with xylose metabolic pathway enzymes such as xylose 
reductase and xylitol dehydrogenase.21,22 Van Vleet J et al. (2008) grew engineered S. 
cerevisiae in D-xylose, and observed that deletion of PHO13 (pho13Δ) improved growth 
in aerobic conditions with xylose as the carbon source.15 Further studies support that 
engineered pho13Δ strains were able to grow on xylose more effectively than wild type 
strains, but this effect is only seen with engineered strains.15,16,17,19 Engineered pho13Δ 
mutant strains grown with glucose show no difference in glucose consumption and 
ethanol production compared to wild type, which was observed in xylose conditions.17 A 
growth phenotype for pho13Δ in non-engineered yeast has yet to be observed.  
Phosphoglycolate Phosphatase Activity  
A recent publication has suggested Pho13p exhibits phosphatase activity towards 
2-phosphoglycolate (2-PG).10 Our lab has independently determined that purified Pho13p 
also exhibits phosphoglycolate phosphatase (PGPase) activity. In photosynthetic 
organisms, 2-phosphoglycolate (fig 6) is produced as a wasteful byproduct of the Calvin 
cycle. This predominantly occurs under aerobic conditions when ribulose-1,5-
bisphosphate carboxylase/oxygenase (RuBisCO) cleaves ribulose-1,5-bisphosphate to 2-
PG and 3-phosphoglycerate instead of only 3-phosphoglycerate.23 To prevent the 
accumulation of 2-PG, a phosphoglycolate phosphatase (PGPase) removes the phosphate 
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group on 2-phosphoglycolate to produce glycolate which can be used in other metabolic 
processes.24,25 Budding yeast, a non-photosynthetic organism, does not currently have a 
known mechanism for producing 2-PG. Therefore, modeling a PGPase function for 
Pho13p in S. cerevisiae remains a challenge. 
 
Figure 6. Phosphoglycolate. A byproduct of the Calvin cycle that requires 
dephosphorylation by a PGPase for subsequent metabolic pathways. Prepared using 
ChemSketch. 
 
PGPases in Non-Photosynthetic Organisms 
 Currently, there is at least one example of PGPase activity identified in another 
non-photosynthetic organism. Pellicer et al. (2003) performed studies of oxidative 
damage in E. coli and found evidence supporting the involvement of a PGPase. Upon 
treatment with bleomycin, an agent for inducing DNA lesions and that often leave 3’-
phosphoglycolate moieties in strand breaks, E. coli strains harboring mutations in the gph 
gene had measurable levels of 2-PG accumulation compared to wild-type extracts. Upon 
repair of the DNA strand breaks, 2-PG is released and it is believed that gph, E. coli 
PGPase gene, cleaves the phosphate group from the liberated 2-PG. Levels of 2-PG were 
indirectly quantified by measuring the amount of inorganic phosphate released when 
bleomycin treated cell extracts were incubated with purified gph. The mutant extracts had 
measureable levels of inorganic phosphate while wild type extracts did not.25  
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Phenotype & Complementation Studies 
Saccharomyces cerevisiae (budding yeast) is a model eukaryotic organism to use 
for phenotypic studies of PHO13. The most obvious reason is that PHO13 is native to 
this organism. Furthermore, S. cerevisiae was the first eukaryotic organism with a 
completely sequenced genome and contains about 45 known genes encoding for HAD 
superfamily proteins.26,10 Budding yeast can be easily grown, are nonpathogenic, and 
have a well-defined genetic system.26 By virtue of S. cerevisiae genetic versatility, a 
deletion library exists for a majority of non-essential yeast genes.27 A deletion strain of 
PHO13 (pho13Δ) is currently available and can be used in an effort to identify a 
phenotype. Early studies disrupting PHO13 in yeast showed that these strains exhibited 
no loss in viability or sporulation.12 
Strategies to assess phosphoglycolate phosphatase activity in S. cerevisiae 
 To confirm that PGPase activity of Pho13p is physiologically relevant, a growth 
phenotype for pho13Δ cells needs to be identified to support the proposed enzymatic 
function. Despite the work with gph25, it remains unclear how 2-PG is generated in non-
photosynthetic organisms. A potential strategy is to take advantage of the fact that 2-PG 
is an inhibitor of triose phosphate isomerase (TPI1 in yeast) and when there is an 
accumulation of 2-PG, triose phosphate isomerase is inhibited.28,29 Triose phosphate 
isomerase is a critical enzyme within the glycolytic pathway that catalyzes the reversible 
reaction of dihydroxyacetone phosphate (DHAP) to D-glyceraldehyde-3-phosphate 
(G3P).28,30 Presumably, if TPI1 in yeast is inhibited, DHAP is not converted to G3P and 
will accumulate as a result.29 In one scenario, this accumulation of DHAP might be 
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alleviated by conversion of DHAP to glycerol via actions of glycerol-1-phosphate 
oxidase (fig 7, pathway 1).   
 
Figure 7. Possible growth phenotypes for pho13Δ  strain. Schematic showing potential 
avenues for investigating growth phenotypes that might result from the accumulation of 
2-PG in budding yeast. 
 
Yeast challenged with hyperosmotic conditions are able to adapt to this growth 
environment through the high osmolarity glycerol (HOG) pathway.31 Yeast produce 
glycerol as a primary osmolyte in response to HOG pathway activation.32,31 As glycerol 
accumulates, the internal environment of the cell becomes more concentrated, reaching 
an isotonic state with the hyperosmotic environment.32 It is possible that pho13Δ cells 
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might have accumulated an excess of glycerol due to DHAP accumulation, and can thus 
adapt to a high salt environment quicker than wild type strains (Fig 8, pathway 1).  
 A second potential approach to pursue (fig 7, pathway 2) is the reported effect of 
DHAP accumulation on inositol-less growth of yeast.33 Inositol is a precursor for lipids 
and phosphates containing inositol that are essential for signaling and membrane 
identity.34 Myo-inositol-3-phosphate synthase catalyzes the rate-limiting step of de novo 
inositol biosynthesis in yeast by catalyzing the conversion of glucose-6-phosphate to 
myo-inositol-3-phosphate and is encoded by INO1. Shi et al. (2005), provided evidence 
that accumulation of DHAP resulting from a loss-of-function mutation of TPI1 resulted 
in a growth phenotype in the absence of exogenous inositol.33 If DHAP accumulates in 
pho13Δ cells, these cells might also exhibit this ‘inositol-less death’ phenotype.  
2-Phosphoglycolate generation in yeast via oxidative stress 
 It is possible that the mechanism(s) in S. cerevisiae that generate 2-PG might be 
insufficient to elicit the desired phenotypes previously described. In an effort to 
accumulate more 2-PG, an oxidative agent, hydrogen peroxide, is introduced to the 
growth environment (fig 8). When hydrogen peroxide is introduced to cells, it causes 
DNA strand breaks at the phosphate backbone via the Fenton reaction (Eq. 1).35,36,37,38 A 
DNA-bound iron, Fe(II), reacts with hydrogen peroxide to yield hydroxide radicals.39 The 
Fe(III) is reduced via NADH to propagate the reaction.39 𝐻!𝑂! + 𝐹𝑒!! →   𝐹𝑒!! +    ∙ 𝑂𝐻 + 𝑂𝐻!    (Eq. 1) 
 
The DNA damage caused by these hydroxide radicals can result in a 3’-phosphoglycolate 
terminus among other moieties (fig 8).39 The 3’-phosphoglycolate terminus blocks the 
DNA polymerase and ligase activity.35 DNA apurinic/apyrimidinic (AP) endonucleases 
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in yeast will repair the strand breaks and liberate 2-PG like E. coli.35,40 Currently, there is 
no known mechanism for the removal of 2-PG and it is not known to spontaneously 
breakdown.36 Thus, yeast strains can be oxidatively stressed in an effort to augment either 
or both of the previously described potential growth phenotypes. 
 
Figure 8. Oxidative damage via hydrogen peroxide. Damage to DNA via hydrogen 
peroxide causes a 3’-phosphoglycolate which must be cleaved from the DNA double 
strand break by DNA repair resulting in 2-PG.36,39 Prepared using ChemSketch. 
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Growth Media 
 S. cerevisiae strains were grown using either complete or synthetic media. Yeast 
extract-peptone-dextrose (YPD) is complete medium used for routine growth of 
S. cerevisiae strains and contains Bacto-yeast extract (Becton Dickinson), Bacto-peptone 
(Becton Dickinson) and D-(+) glucose (Sigma-Aldrich).26 Synthetic minimal glucose 
media (SD) contains Bacto-yeast nitrogen base (YNB) (Sunrise Science Products) that 
supplies vitamins, trace elements and salts, ammonium sulfate (Sigma-Aldrich) as a 
nitrogen source and D-(+)-glucose as a carbon source.26 If SD is supplemented with 
adenine, uracil, and various amino acids, it is referred to as synthetic complete 
media (SC). However, growth selection can be performed for strains of S. cerevisiae by 
dropping out one or more of these additives. In this study, synthetic minimal glucose 
media without uracil (SD-Ura) was used by mixing SD with Complete Supplement 
Mixture without uracil (CSM-Ura) (Sunrise Science Products). SD-Ura media without 
Inositol (SD-Ura-Inositol) was made the same way as SD-Ura but using YNB without 
Inositol (YNB-Inositol) (Sunrise Science Products) instead of YNB. For all strains of 
E. coli, Luria-Bertani (LB) broth with ampicillin (Amp) (100 µg/mL) was used. The 
same formulations were used for solid media with the addition of Bacto-agar (Becton 
Dickinson).  
Shuttle vectors allowed expression of the studied gene in two different organisms, 
S. cerevisiae and E. coli. Two shuttle vectors were used in the experimental studies; 
pYES2 (Invitrogen) & pRS316.41 Each vector contained an ampicillin resistance gene 
(AmpR) and the URA3 gene (fig 9 & 10) that encoded Orotidine-5’-phosphate 
decarboxylase to allow for selection in E. coli and S. cerevisiae, respectively. Selection of 
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transformants in E. coli occurred in the presence of ampicillin. To select for 
transformants in S. cerevisiae, SD-Ura growth media was used. Since the host yeast 
strains have the URA3 gene disrupted (ura3Δ0), these strains cannot grow without uracil 
because orotidine-5’-phosphate decarboxylase is not available to catalyze uridine-5’-
monophosphate (UMP) formation. This ensured only cells successfully transformed with 
the plasmids are able to grow on SD-Ura media. Additionally, the two different vectors 
used have different promoters to drive gene expression. The pYES2 vector has a 
galactose inducible (PGAL1) promoter, which was inducible when galactose was used in 
growth media and repressed in glucose media (fig 9).42 The pRS316 plasmid had an 
alcohol dehydrogenase 1 (PADH1) promoter allowing constitutive expression of the gene 
(fig 10).42  
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Figure 9. Vector pYES2 used in the experimental studies. Created with SnapGene.	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Figure 10. Vector pRS316 used in the experimental studies. Created with SnapGene. 	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The two empty vectors were transformed into various S. cerevisiae host strains (table 1). 
For complementation studies, the vectors with PHO13 or gph were also transformed into 
the pho13Δ strain (table 1).   
Table 1. Yeast Strains used in this study. 
Host Strain Genotype Growth Media Plasmids Strain Notation 
G Genotype Growth Media Plasmids Strain Notation 
WT 
MATa, 
his3Δ1, 
leu2Δ0, 
met15Δ0,
ura3Δ0 
YPD - WT 
SD-Ura 
pYES2 WT (pYES2) 
pRS316 WT (pRS316) 
pho13Δ 
MATa, 
his3Δ1, 
leu2Δ0, 
met15Δ0,
ura3Δ0, 
pho13Δ 
YPD - PHO13Δ 
SD-Ura 
pYES2 PHO13Δ (pYES2) 
pRS316 PHO13Δ (pRS316) 
pYES2-PHO13 PHO13Δ (pYES2-PHO13) 
pYES2-GPH PHO13Δ (pYES2-GPH) 
pRS316-PHO13 PHO13Δ (pRS316-PHO13) 
pRS316-GPH PHO13Δ (pRS316-GPH) 
tpi1Δ 
MATa, 
his3Δ1, 
leu2Δ0, 
met15Δ0,
ura3Δ0, 
tpi1Δ 
YPD - TPI1Δ 
SD-Ura 
pYES2 TPI1Δ (pYES2) 
pRS316 TPI1Δ (pRS316) 
ino1Δ 
MATa, 
his3Δ1, 
leu2Δ0, 
met15Δ0,
ura3Δ0, 
ino1Δ 
SD-Ura 
pYES2 INO1Δ (pYES2) 
pRS316 INO1Δ (pRS316) 
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Restriction Digest Analysis  
 Bacterial transformants of clones that potentially contained the bacterial gph gene 
in the pYES2 vector were purified by alkaline lysis43 previously in the lab. To confirm if 
clones contained the gph gene correctly inserted in the pYES2 vector between BamHI 
and EcoRI multiple cloning sites, restriction enzyme digestion was performed with 
BamHI-HF and EcoRI-HF (New England Biolabs). Restriction digests were carried out at 
37 °C for 1 hour in 50 µL volumes with 10 µL of plasmid clones or 6 µg of pYES2 with 
50 units of each enzyme. Digests were analyzed on a 0.7% Agarose gel run at 80 V for 
90 minutes and then stained with 0.5 µg/µL ethidium bromide for 45 minutes.  
Plasmid Midiprep Purification 
E. coli DH5α cells containing a pYES2-GPH clone confirmed to contain the gene 
were streaked to single colonies on LB plates with 100 µg/mL ampicillin. An isolated 
colony was used to inoculate 50 mL of LB with 100 µg/mL ampicillin and incubated 
overnight for approximately 16 hours at 37 °C with shaking at 225 rpm. A total of 36 mL 
of cells was harvested in twelve microcentrifuge tubes by centrifugation at 13,148 
relative centrifugal force (RCF) for 2 minutes. Then pellets were resuspended with a 
filter-sterilized solution (solution I) containing 50 mM glucose and 10 mM 
Ethylenediaminetetraactic acid (EDTA). Following this, a second solution, (solution II) 
was prepared containing 0.13 M sodium hydroxide (NaOH) and 0.66% sodium dodecyl 
sulfate (SDS) to rupture cells and denature proteins. A third filtered solution (solution III) 
was then added containing 1 M potassium acetate to neutralize the solution and in the 
process renature plasmid DNA but precipitate chromosomal DNA. Plasmids were 
collected and treated with 0.044 mg/mL DNase-free bovine pancreatic RNase A (Sigma-
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Aldrich) in 10 mM Tris-HCl (pH 8.0) with 1 mM EDTA (TE Buffer) for 30 minutes at 
37 °C. A phenol:chloroform (1:1) mixture and chloroform were used sequentially to 
remove residual protein. The DNA plasmids and tRNA were precipitated with 
approximately 66.7% ethanol at -80 °C then centrifuged in 4 °C at 13,148 RCF for 
30 minutes. Pellets were rinsed with 70% ethanol, centrifuged in 4 °C at 13,148 RCF for 
5 minutes and then vacuum-dried using a Speed-Vac centrifuge for approximately 
20 minutes. Each pellet was resuspended in 16.8 µL of cold sterile water and then pooled 
together into one tube. To this tube was added a mixture of 6.5% polyethylene glycol 
(PEG) and 0.4 M NaCl to remove tRNAs by overnight incubation (~24 hrs) at 4 °C. 
Pellets were rinsed with 70% ethanol, centrifuged at 4 °C and 13,148 RCF for 5 minutes 
and then vacuum-dried using a Speed-Vac centrifuge for approximately 20 minutes. The 
plasmid pellet was resuspended in 120 µL of cold sterile water.  
Plasmid Quantitation and DNA Sequencing 
DNA concentrations were determined by measuring the absorbance of plasmid 
midiprep samples using a spectrophotometer at 260 nm. Concentration of DNA was 
determined using the relationship:  𝐴!"# = 1.0 =    !"!"  !"           (Eq. 2) 
 The gph insert in pYES2 was confirmed to be free of mutation using DNA 
sequencing analysis performed by Genewiz, Inc. Sample preparation guidelines were 
followed according to Genewiz, Inc. 
Yeast Transformation  
 Yeast transformations were adapted from the Chen et al. protocol.44 Yeast 
cultures of the desired strains were inoculated and grown at 30 °C in YPD media 
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overnight. The following morning, the culture OD600 was measured and then diluted in 
YPD to 0.1 and grown to an OD600 of approximately 1.0. Following that, 1 mL of the 
culture was centrifuged at 6,708 RCF for 2 minutes at room temperature. After removing 
supernatant, the yeast pellet was briefly resuspended with approximately 1 µg DNA at a 
concentration of 500 ng/µL. The same volume of filter-sterilized distilled water (dH2O) 
was used for resuspending pellets for control transformations. After that, 100 µL of a 
mixture of 39.6% PEG 3350, 0.1 M DTT, and 0.2 M lithium acetate was used to fully 
resuspend the cell pellet and DNA. The resuspension was incubated at 45 °C for 
30 minutes. The total volume of mixture was spread on SD-Ura plates and grown at 
30 °C for 48-72 hours to isolate individual yeast transformants.  
Yeast Growth Under Hyperosmotic Conditions 
 Overnight cultures in YPD or SD-Ura were inoculated from individual colonies 
and grown at 30 °C with shaking. The OD600 was measured using a spectrophotometer 
and diluted in 4 mL to a desired OD600 of 0.05. Once cultures grew to an OD of 1, 
cultures were put on ice and serially diluted 10-fold with dH2O in 100 µL volumes (fig 
11). Following that, 5 µL of each dilution was spot plated, smallest dilution to largest, left 
to right on plates (fig 12) with the appropriate growth media with or without 1M NaCl. 
Cells were grown at 30 °C for approximately 48-72 hours. 
To ensure any observed changes in growth under hyperosmotic conditions were 
not the result of different starting ODs, the volumes of cell culture diluted in the first 
dilution were adjusted accordingly: assuming an OD600 of 1 is equivalent to 
3.0*107 cells45, 10 µL was divided by the strain OD600 to determine the initial volume 
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diluted to 100 µL with dH2O. The subsequent dilutions were performed identically for all 
strains (fig 11). 
 
 
 
Figure 11. Serial dilutions schematic of yeast cultures. Dilutions were carried out from 
10-1 to 10-5. Prepared using Adobe Illustrator CC. 
  
 
Figure 12. Spot plate schematic.  Each dilution, smallest to largest, spotted left to right. 
Each row represents either a different strain or condition tested. Prepared using Adobe 
Illustrator CC. 
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Yeast Growth Under Inositol-Free Conditions 
Cells were grown exclusively in SD-Ura media and spot plated, as described 
above, on SD-Ura media and SD-Ura-Inositol. To guard against the possibility that 
residual inositol in the dilutions could impact growth effects on inositol-free plates, 1mL 
of culture was pelleted at 1,677 RCF for 5 minutes and washed twice with 1 mL dH2O 
prior to performing serial dilutions. 
Yeast Growth Under Oxidative Stress 
 Cells were grown in either YPD or SD-Ura and treated as described previously, 
with the following changes: Hydrogen peroxide (30%) (Macron Fine Chemical) was 
filter-sterilized and spread onto the appropriate solid growth media at varying 
concentrations and allowed to dry at 30 °C prior to plating. Once plates were dry, cells 
were spot plated as described above and grown at 30 °C for 48 hours.  
 As a more quantitative method to assess sensitivity to oxidative stress, overnight 
cultures grown in the appropriate media were diluted to an OD600 of 0.1 in 30 mL of 
media. The 30 mL culture was grown to an OD of approximately 0.5 and then split 
evenly into five, 4 mL cultures. Filter-sterilized hydrogen peroxide in a 10 µL volume of 
increasing concentrations was then added to each culture tube. The untreated tube 
received 10 µL of sterile dH2O. Cultures were placed in 30 °C incubator with shaking for 
90 minutes. Following this, serial dilution and spot plating was performed for each tube 
on the appropriate solid media plates and placed in 30 °C incubator for 48 hours. 
Sensitivity to H2O2 was quantified by dividing the number of colony-forming 
units (CFUs) grown under H2O2 exposure by the number of CFUs grown under untreated 
	   27	  
conditions. Without exception, colony counts derived from the 10-3 dilution were used for 
these calculations. Results were normalized using the relationship: %  𝑆𝑢𝑟𝑣𝑖𝑣𝑎𝑙   = !"#"$%  !"#$%  (!!!!)!"#"$%  !"#$%  (!"#$%&#%') (100)  (Eq. 3) 
 
Complementation Studies 
Strains transformed with empty vectors or vectors containing PHO13 or gph were 
grown in SD-Ura and treated in liquid media as described above. Overnight cultures were 
split evenly and treated with either 0.8 mM H2O2 or untreated with sterile dH2O and 
grown for 90 minutes. For these experiments, a wild type strain was treated in parallel for 
all the experiments.  
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Restriction Digest Analysis of pYES2-GPH 
The majority of the plasmids used in this study were previously prepared by other 
members of the lab (table 1). One plasmid that remained to be constructed was pYES2-
GPH (fig 13). This plasmid was intended to be used for complementation studies of 
pho13Δ. The pYES2-GPH plasmid was constructed by ligation of BamHI/EcoRI-
digested pYES2 and gel-purified gph, previously excised from pRS316-GPH in the lab 
using the same enzymes, at three different molar ratios of plasmid to insert (1:0.5, 1:1, 
and 1:2). Twelve colonies were inoculated for analysis, four from each transformation 
plate that had comparable colony counts.  
 
  
Figure 13. Plasmid map showing the insertion of gph between restriction sites for 
enzymes BamHI and EcoRI. In the absence of the gene, the restriction sites are only 30 
bp apart. 
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To confirm whether the sub-cloning was successful, restriction digestion analysis 
was performed on the twelve clones and a control plasmid, pYES2. Specifically, all 
plasmids were digested with EcoRI and BamHI as gph was ligated between those 
restriction sites. Based on the restriction digest results (fig 14), the sub-cloning was 
successful. The 5,825 bp band, representing pYES2, was present in all lanes. In lane 8, 
the control plasmid, no gph band was observed (771 bp) whereas all of the clones were 
observed to produce this band. This confirmed that gph was successfully ligated into 
pYES2.  
 
Figure 14. Verification of successful sub-cloning of pYES2-GPH digested with 
EcoRI and BamHI. Lane 1. HindIII molecular weight markers. Lane 2-7,9-14: pYES2-
GPH; Lane 8: pYES2. 
 
Quantitation of pYES2-GPH Midiprep 
One of the confirmed clones of pYES2-GPH was purified for subsequent 
transformation into pho13Δ strains. Following midiprep purification, the concentration of 
the plasmid needed to be determined prior to yeast transformation. A final concentration 
of 575 ng/µL was calculated based on the measured absorbance of 0.115 A for a 1:100 
dilution of the midiprep at 260 nm. 
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Table 2. Quantitation of pYES2-GPH Midiprep 
Plasmid Dilution Factor A260 Concentration 
(ng/µL) 
pYES2-GPH 100 0.115 575 
 
 
The sample was sent for DNA sequencing analysis to Genewiz, Inc. following 
sample preparation guidelines and was determined to contain no mutations within the 
open reading frame. 
Transformation of pYES2-GPH into pho13Δ   
The sequence-verified pYES2-GPH clone was subsequently transformed into 
pho13Δ. No growth was observed for pho13Δ transformed without plasmid (table 3). 
Since the plates do not have uracil only cells transformed with a pYES2 vector containing 
an URA3 marker are able to grow. A colony count ~315 was observed for pho13Δ cells 
transformed with pYES2-GPH (table 3), confirming the transformation was successful.  
Table 3. Yeast transformation results 
Plasmid Transformed Host Colony Counts 
pYES2-GPH pho13Δ 315 
- pho13Δ 0 
 
Growth response to hyperosmotic stress 
 Wild-type strains were cultured in parallel with pho13Δ cells strains. From liquid 
culture, serial dilutions of the strains were spotted simultaneously on SD-Ura plates and 
SD-Ura plates containing a high salt environment (1M NaCl). If the perceived 
accumulation of 2-PG in pho13Δ cells resulted in a greater accumulation of intracellular 
glycerol, it was expected that pho13Δ cells would be able to adapt more quickly than WT 
cells to the hyperosmotic environment. 
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A. B.  
 
Figure 15. Hyperosmotic stress spot platting. WT and pho13Δ were grown on minimal 
media with and without high salt. A. SD-Ura. B. SD-Ura 1M NaCl.  Top to bottom; WT 
(pYES2), PHO13Δ (pYES2), WT (pRS316), PHO13Δ (pRS316). Serial dilutions left to 
right, 10-1, 10-2, 10-3, 10-4, 10-5. Shown is a representative experiment of three 
independent trials. 
 
As shown, all four strains clearly display a lag in growth under hyperosmotic 
conditions (fig 15B) compared to normal growth conditions (fig 15A). The pho13Δ cells 
transformed with the pRS316 empty vector appeared to grow slightly faster than wild-
type strains with the same vector under hyperosmotic conditions, but this behavior was 
reversed with the same strains transformed with the pYES2 vector (fig 15B). This 
variability among strains with different vector backgrounds was not due to differences in 
cell numbers as the same dilutions grew comparably on SD-Ura plates (fig 15A). Since a 
phenotype could not be observed that was independent of the empty vector transformed, 
complementation experiments were not attempted and hyperosmotic stress experiments 
were not pursued further.  
Inositol-less death growth response 
Within the glycolytic pathway, triose phosphate isomerase (TPI) catalyzes the 
reversible reaction of dihydroxyacetone phosphate (DHAP) to D-glyceraldehyde-3-
phosphate (G3P).28,30 When there is an accumulation of 2-PG, TPI activity will be 
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inhibited causing the accumulation of DHAP.28,29 The accumulation of DHAP inhibits 
myo-inositol-3-phosphase synthase, encoded by INO1, the enzyme that catalyzes the 
conversion of glucose-6-phosphate to myo-inositol-3-phosphate.33 If this pathway is 
inhibited and inositol cannot be produced, yeast will not able to grow in an environment 
that lacks inositol.33 To test whether pho13Δ strains exhibited a similar phenotype, strains 
were grown in liquid media and then spot plated simultaneously on both SD-Ura and SD-
Ura-Inositol plates (fig 16). 
A.  B.  
Figure 16: Inositol-free spot plating. Growth of WT, pho13Δ and ino1Δ strains on SD-
Ura (A) and SD-Ura-Inositol (B). Top to bottom: WT (pRS316), PHO13Δ (pRS316), 
INO1Δ (pRS316). Serial dilutions left to right, 10-1, 10-2, 10-3, 10-4, 10-5. 
 
 Based on the figure 16, pho13Δ appeared to grow comparably to WT under 
inositol-free conditions. The ino1Δ strain was included as a positive control for inositol-
less death and to confirm that the SD-Ura-Inositol plates were correctly formulated. As 
shown in figure 16A, ino1Δ was able to grow under normal conditions comparable to the 
other strains, but exhibited a significant loss-of-growth phenotype without external 
inositol (fig 16B).  
 The possibility remained that residual inositol from liquid cultures could have 
potentially masked an inositol-free growth phenotype for pho13Δ cells when spot plating. 
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To minimize cell access to external inositol, cells from liquid cultures were washed prior 
to plating on the same solid media. 
A. B.  
Figure 17: Washed inositol-free spot plating. WT, pho13Δ, and ino1Δ grown on SD-
Ura (A) and SD-Ura-Inositol (B). Washed twice prior to plating. Top to bottom: WT 
(pRS316), PHO13Δ (pRS316), INO1Δ (pRS316). Serial dilutions left to right, 10-1, 10-2, 
10-3, 10-4, 10-5.  
 
As shown in figure 17, washing cells prior to plating did not decrease cells 
viability for any of the strains (fig 17A). Furthermore, the growth phenotype of ino1Δ 
strains on inositol-free media was not enhanced with the washing step. Also, washing had 
no significant impact on the growth behavior of pho13Δ cells on inositol-free media that 
might closer reflect the inositol-less growth phenotype of ino1Δ strains.   
Response to Oxidative Stress 
 Experiments involving hyperosmotic stress and inositol-free growth were based 
on the assumption that there was sufficient 2-PG in cells to inhibit TPI1 and potentially 
elicit these effects. It was possible that the lack of a phenotype for those growth responses 
could be due to an insufficient level of 2-PG in cells. In an effort to increase the amount 
2-PG being produced in yeast strains, cells were challenged under oxidative stress 
conditions. To do this, hydrogen peroxide was introduced to cells during their growth. 
The hydrogen peroxide causes DNA strand breaks and upon DNA repair, 2-PG is 
released into the cells.39,35  
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 The initial strategy for introducing oxidative stress was by application of 
hydrogen peroxide to plates. Increasing concentrations of hydrogen peroxide were tested 
to identify a desirable concentration range to use (fig 18).  
A. B.  
C. D.  
E. F.  
Figure 18. Spot plating of yeast strains on rich media with increasing concentrations 
of hydrogen peroxide. The top row represents WT and the bottom row represents 
pho13Δ. The various hydrogen peroxide concentrations applied to each plate are 0mM 
(A), 0.5mM (B), 1.0mM (C), 1.5mM (D), 2.0mM (E), 5.0mM (F). Serial dilutions left to 
right, 10-1, 10-2, 10-3, 10-4, 10-5. 
 
It can be seen that 5 mM H2O2 was lethal for both strains (fig 18F). Comparison of 
growth between WT and pho13Δ strains using concentrations between 0.5 mM and 2 mM 
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indicated no obvious phenotype on rich media (fig 18B-E). However, the results with 
these concentrations were not consistent and difficult to be replicate due to issues with 
hydrogen peroxide absorption prior to spot plating. 
 Based on the challenges faced when attempting to quantify cell growth using this 
method, a more controlled approach was used for treating cells with hydrogen peroxide. 
Martins et al. (2014) previously treated the same yeast strain (genetic background 
BY4741) with hydrogen peroxide at varying concentrations in liquid culture for a fixed 
amount of time and then spot plated to compare viability relative to untreated cultures.37 
To test for the feasibility of this assay, wild type S. cerevisiae was grown in liquid 
culture, and then treated with increasing concentrations of hydrogen peroxide and plated 
after 90 minutes of growth. 
 
Figure 19. Determination of a desirable range of hydrogen peroxide in rich media. 
Wild Type cells were treated with 0, 1, 1.5, 2, and 5mM H2O2 in rich media. Serial 
dilutions left to right, 10-1, 10-2, 10-3, 10-4, 10-5.  
 
As figure 19 shows, cells are not able to grow effectively at concentrations greater than or 
equal to 2 mM H2O2 when treated in liquid culture. Additionally, the concentration range 
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from 0 mM to 1 mM H2O2 was shown to elicit a significant decrease in viability. This 
same concentration range was used by Martins et al. (2014) and thus chosen for future 
experiments. 
 When cultures of WT and pho13Δ strains were grown in rich media and treated 
with hydrogen peroxide, no significant difference in strain growth was observed (fig 20). 
In brief, the percentage of survival was determined by dividing the number of colonies in 
the 10-3 dilution for each treatment by the control (0mM H2O2) treatment. Figure 19 
shows a clear decrease in cell survival for both strains as the concentration of hydrogen 
peroxide increased. However, there was no significant difference between the WT and 
pho13Δ survival at the hydrogen peroxide concentrations tested (fig 20). The knockout 
strain of TPI1 (tpi1Δ) was also included as a control and was no more susceptible to 
hydrogen peroxide than either WT or pho13Δ. 
	  
Figure 20.  Growth of strains in rich liquid media under oxidative stress. Shown is 
the mean and standard error of three independent biological replicates of each strain. 	  
 Since there was no obvious difference in strain survival to oxidative stress on rich 
media (YPD), experiments were repeated using minimal media (SD-Ura) in an effort to 
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observe if a difference could be observed with limited nutrients available. When WT and 
pho13Δ strains were oxidatively stressed in limited media, there appeared to be a 
difference in strain survivability with the pho13Δ strain showing greater susceptibility 
(fig 21). Control strains of ino1Δ and tpi1Δ were also tested to ensure that the enhanced 
suspectibility might be due specifically to the deletion of the PHO13 gene and not just 
any gene deletion. Figure 21 shows that these strains appear to exhibit less susceptibility 
to oxidative stress than pho13Δ. 
	  
Figure 21. Growth of strains in limited liquid media under oxidative stress. Shown is 
the mean and standard error of three independent biological replicates of WT (pRS316), 
PHO13 (pRS316), INO1Δ (pRS316), and TPI1Δ (pRS316) treated with five different 
concentrations of H2O2.  
  
If pho13Δ was exhibiting sensitivity to oxidative stress due to elevated 2-PG 
levels, this might also result in an observable phenotype on inositol-free media in the 
presence of H2O2. Each of the four strains was additionally tested for the ability to grow 
on inositol-free media under oxidative stress conditions. In addition to growing on media 
without inositol, strains were also tested for the ability to grow on media lacking inositol 
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supplemented with lithium. Previous work has shown that lithium causes a decrease in 
intracellular inositol in yeast.33 Consequently, if the inositol depletion effects of pho13Δ 
are real, but difficult to observe, the presence of lithium might help enhance those effects. 
 For three of the strains (WT, pho13Δ, tpi1Δ), the loss of survivability on normal 
minimal media did not appear to be enhanced on either of the additional media lacking 
inositol (fig 22-24). This suggests that the apparent enhanced susceptibility of pho13Δ to 
oxidative stress (fig 21) does not appear to involve the inhibition of TPI1. Furthermore, it 
was not expected that tpi1Δ would grow comparably on normal minimal media compared 
to minimal media lacking inositol (fig 23) based on the inositol-less death phenotype of a 
loss-of-function tpi1 mutant.33 
 
Figure 22. Growth of WT strains in limited liquid media under oxidative stress. 
Shown is the mean and standard error of three independent biological replicates of WT 
(pRS316) on SD-Ura, SD-Ura-Inositol, and SD-Ura-Inositol 40 mM Li+.  
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Figure 23. Growth of tpiΔ  strains in limited liquid media under oxidative stress. 
Shown is the mean and standard error of three independent biological replicates of TPI1Δ 
(pRS316) on SD-Ura, SD-Ura-Inositol, and SD-Ura-Inositol 40 mM Li+. 
   
 
	  
Figure 24. Growth of pho13Δ  strains in limited liquid media under oxidative stress. 
Shown is the mean and standard error of three independent biological replicates of 
PHO13Δ (pRS316) on SD-Ura, SD-Ura-Inositol, and SD-Ura-Inositol 40 mM Li+. 
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To confirm these results were not due to an issue with the inositol-free plates, 
ino1Δ strains were also tested. As expected, the loss of cell survival of ino1Δ strains 
could not be observed on plates without inositol, confirming the inositol-less death 
phenotype of this strain (fig 25) and the lack of inositol on the plates. 
 
Figure 25. Growth of ino1Δ  strains in limited liquid media under oxidative stress. 
Shown is the mean and standard error of three independent biological replicates of 
INO1Δ (pRS316) on SD-Ura, SD-Ura-Inositol, and SD-Ura-Inositol 40 mM Li+. 
 
A direct comparison of strains in media lacking inositol indicates pho13Δ appears 
to still exhibit a slight hypersensitivity to oxidative stress (fig 26) as it did for minimal 
media with inositol (fig 21). However, this hypersensitivity of pho13Δ appears to have 
weakened further on plates without inositol supplemented with lithium (fig 27).   
 
	   42	  
 
Figure 26. Growth of strains in limited media without inositol under oxidative 
stress. Shown is the mean and standard error of three independent biological replicates of 
WT (pRS316), pho13Δ (pRS316), tpi1Δ (pRS316), ino1Δ (pRS316) on SD-Ura-Inositol. 
 
 
 
 
Figure 27. Growth of strains in limited media without inositol supplemented with 
lithium under oxidative stress. Shown is the mean and standard error of three 
independent biological replicates of WT (pRS316), pho13Δ (pRS316), tpi1Δ (pRS316), 
ino1Δ (pRS316) on SD-Ura-Inositol 40 mM Li+. 
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Complementation Studies  
The results in figure 21 suggest a growth phenotype for pho13Δ may exist when 
cells are oxidatively stressed in limited media. However, preliminary evidence suggests 
this phenotype does not appear to be due to an inhibition of TPI1 based on experiments 
with inositol-free media. To confirm if the phenotype seen was directly due to a loss of 
Pho13p function, complementation studies were attempted using two different sets of 
plasmids: pRS316-based vectors (constitutive expression of plasmid-borne PGPases) and 
pYES2-based vectors (galactose-inducible expression of plasmid-borne PGPases).  
As shown in figure 28, in 0.8mM hydrogen peroxide, there was an apparent 
difference in cell survivability between WT and pho13Δ strains as previously seen. When 
Pho13p was added back to cells, the susceptibility of cells appeared to revert partially 
back to that of WT, whereas cells with gph, the E. coli PGPase, introduced back did not 
appear to revert phenotype (fig 28). The fact that a known PGPase, gph, could not 
complement the putative phenotype suggested the results may not be reliable and 
warranted another set of complementation experiments using a different expression 
vector, pYES2.  
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Figure 28. Growth of strains in limited liquid media under oxidative stress. Shown is 
the mean and standard error of three independent biological replicates of WT (pRS316), 
PHO13Δ (pRS316), PHO13Δ (pRS316-GPH), PHO13Δ (pRS316-PHO13) on SD-Ura. 
 
 When pYES2 vectors were used to study complementation, a different trend was 
observed (fig 29). The hydrogen peroxide appeared to have a greater impact on the 
growth of the wild type strain than the pho13Δ strain. When PHO13 was reintroduced in 
the vector, it had a comparable growth to the pho13Δ strain and not the wild type. The 
strain with gph introduced also had a comparable growth to the pho13Δ strain as well. 
Not only had neither PGPase reversed the phenotype in this scenario, but the phenotype 
itself appeared to have been reversed. As was observed for hyperosmotic growth 
conditions (fig 15), the growth behavior of the WT and pho13Δ strains does not appear to 
be independent of the empty vector used.  
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Figure 29. Growth of strains in limited liquid media under oxidative stress. Shown is 
the mean and standard error of three independent biological replicates of WT (pYES2), 
PHO13Δ (pYES2), PHO13Δ (pYES2-GPH), PHO13Δ  (pYES2-PHO13) on SD-Ura. 
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 While previous experiments in the lab have reproducibly shown that purified 
Pho13p exhibits PGPase activity, identifying a growth phenotype in S. cerevisiae that 
supports this enzymatic activity remains to be determined. To this end, pho13Δ strains 
were challenged within high osmotic environments. In theory, an accumulation of 2-PG 
in pho13Δ strains might allow cells to adapt to the high salt environment more readily 
through TPI inhibition. However, while there appeared to be a slight difference between 
wild type and pho13Δ strains to adapt to these conditions in minimal media, these 
observed differences were reversed depending on the empty vector used to maintain 
selective growth. Cells were alternatively stressed oxidatively in an effort to boost levels 
of 2-PG in cells based on the literature regarding DNA oxidative damage.39 Under limited 
nutrient growth conditions, there was an apparent difference in growth suggesting 
pho13Δ strains were more susceptible to death under oxidative stress. However, similar 
to the osmotic stress experiments, the observed differences between wild type and 
pho13Δ strains to oxidative stress susceptibility swapped depending on the vector used to 
maintain growth in minimal media.  
In both experimental procedures, when the pRS316 empty vector was used, the 
pho13Δ strain exhibited the predicted phenotypes. In contrast, the WT and pho13Δ strain 
phenotypes switched when using the pYES2 empty vector. An examination of the 
elements of both vectors revealed a few differences including different promoters to drive 
gene expression and a different origin of replication for yeast (fig 9 & 10). The pYES2 
has a galactose inducible (PGAL) promoter and pRS316 has an alcohol dehydrogenase 1 
(PADH1) promoter.42 However, the empty vectors have no genes inserted after these 
promoters so they would not be expected to have an impact on the growth of strains. The 
	   48	  
pYES2 vector has a 2 micron origin of replication (2µ  ori) while the pRS316 has a 
centromere sequence/autonomously replicating sequence (CEN/ARS) origin of 
replication.46,47 The origin of replication in the pYES2 vector results in a high copy 
number of vectors per cell (typically 50 plus copies), and this can result in a metabolic 
burden to the yeast cell.46 Though no PGPase is being expressed from this plasmid, the 
URA3 gene is still making orotidine-5’-phosphate decarboxylase in excess. This could be 
a reason why the pYES2 empty vectors have not elicited the same phenotype in yeast 
cells compared to the pRS316 empty vectors. The CEN/ARS origin of replication on the 
pRS316 vector essentially allows it to copy in the same manner as the yeast genome, thus 
it only makes a single copy per cell.47 Based on these preliminary evidence using these 
two empty vectors, it might be prudent to continue phenotypic studies with only the 
pRS316 empty vector. In support of this, preliminary complementation studies using the 
pRS316 vector to reintroduce PHO13 appeared to indicate phenotype reversal may be 
happening.  
 Additional deletion strains, tpi1Δ and ino1Δ, were included throughout the study 
to serve as controls but provided some surprising results too. Inhibition of TPI was also 
used as the basis to investigate the possibility that cells lacking Pho13p might exhibit 
inositol-free growth defects. In the literature, a missense tpi1 mutation, N65K, reported to 
cause a loss-of-function in the gene additionally resulted in an inositol-less death 
phenotype.33 However, tpi1Δ did not exhibit this phenotype in our studies. While the 
N65K mutation in TPI1 resulted in a loss of function for the gene, the mutation itself 
resided in the dimer interface region of Tpi1p.33 The strain in this study, tpi1Δ, was 
completely missing a copy of TPI1 and thus loss of function was by a different 
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mechanism. It is possible that the inositol-free growth phenotype of the N65K mutant 
resulted from the disruption of dimerization instead of simply a loss of function. In 
contrast, the deletion strain of Ino1p did exhibit the expected inositol-less death and was 
thus an effective positive control for observing this phenotype. 
It might likely be prudent to carry further repetitions of these oxidative stress 
experiments at single concentrations of hydrogen peroxide. There remained considerable 
variability in strain response to oxidative stress from experiment to experiment that 
complicated data analysis possibly due to the variability of the hydrogen peroxide 
potency. Hydrogen peroxide is very unstable and temperature changes and other 
conditions can affect its potency. Ideally, any experiments conducted with this chemical 
should have all relevant strains tested on the same day to account for this variability. 
Otherwise, results across experiments likely carry additional experimental error due to 
the potency of the hydrogen peroxide varying from day to day. Because of the instability 
of hydrogen peroxide it might also be worthwhile to oxidatively stress cells by 
independent means, possibly using a different chemical such as bleomycin25 known to 
elicit 3-phosphoglycolate overhangs.36,39 
 The biggest caveat to these phenotypic studies remains based on any effects 
observed on the perceived inhibition of TPI function in cells. While the ability of 2-PG to 
inhibit TPI function is well known33, having the ability to directly measure its generation 
in yeast cells would prove fruitful. As a future direction, the pho13Δ strain will be 
examined using ion-chromatography-mass spectrometry (IC-MS) to directly measure     
2-PG in cells.48 This will be done in collaboration with Dr. John Knight at the University 
of Alabama at Birmingham. 
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